134 related articles for article (PubMed ID: 32145513)
21. Nonalcoholic fatty liver in patients with Laron syndrome and GH gene deletion - preliminary report.
Laron Z; Ginsberg S; Webb M
Growth Horm IGF Res; 2008 Oct; 18(5):434-438. PubMed ID: 18462969
[TBL] [Abstract][Full Text] [Related]
22. Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome.
L'Allemand D; Eiholzer U; Schlumpf M; Torresani T; Girard J
Horm Res; 2003; 59(5):239-48. PubMed ID: 12714788
[TBL] [Abstract][Full Text] [Related]
23. IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome.
Laron Z; Kauli R; Lapkina L; Werner H
Mutat Res Rev Mutat Res; 2017; 772():123-133. PubMed ID: 28528685
[TBL] [Abstract][Full Text] [Related]
24. Patterns of ovarian growth and development in cattle with a growth hormone receptor deficiency.
Chase CC; Kirby CJ; Hammond AC; Olson TA; Lucy MC
J Anim Sci; 1998 Jan; 76(1):212-9. PubMed ID: 9464901
[TBL] [Abstract][Full Text] [Related]
25. Transgenic Wuzhishan minipigs designed to express a dominant-negative porcine growth hormone receptor display small stature and a perturbed insulin/IGF-1 pathway.
Li F; Li Y; Liu H; Zhang X; Liu C; Tian K; Bolund L; Dou H; Yang W; Yang H; Staunstrup NH; Du Y
Transgenic Res; 2015 Dec; 24(6):1029-42. PubMed ID: 26510874
[TBL] [Abstract][Full Text] [Related]
26. A half-century of studies of growth hormone insensitivity/Laron syndrome: A historical perspective.
Rosenbloom AL
Growth Horm IGF Res; 2016 Jun; 28():46-50. PubMed ID: 26276451
[TBL] [Abstract][Full Text] [Related]
27. Obese adults with primary growth hormone resistance (Laron Syndrome) have normal endothelial function.
Shechter M; Ginsberg S; Scheinowitz M; Feinberg MS; Laron Z
Growth Horm IGF Res; 2007 Apr; 17(2):165-70. PubMed ID: 17320443
[TBL] [Abstract][Full Text] [Related]
28. Assessing insulin sensitivity and resistance in syndromes of severe short stature.
Guevara-Aguirre J; Teran E; Lescano D; Guevara C; Guevara A; Saavedra J; Procel P; Wasserfall C; Gavilanes AWD
Growth Horm IGF Res; 2020; 53-54():101339. PubMed ID: 32763832
[TBL] [Abstract][Full Text] [Related]
29. Insulin resistance depends on GH counter-regulation in two syndromes of short stature.
Guevara-Aguirre J; Guevara A; Bahamonde M
Growth Horm IGF Res; 2018 Feb; 38():44-48. PubMed ID: 29306561
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone (GH) insensitivity due to primary GH receptor deficiency.
Rosenfeld RG; Rosenbloom AL; Guevara-Aguirre J
Endocr Rev; 1994 Jun; 15(3):369-90. PubMed ID: 8076588
[TBL] [Abstract][Full Text] [Related]
31. Novel growth hormone receptor gene mutation in a patient with Laron syndrome.
Arman A; Yüksel B; Coker A; Sarioz O; Temiz F; Topaloglu AK
J Pediatr Endocrinol Metab; 2010 Apr; 23(4):407-14. PubMed ID: 20583548
[TBL] [Abstract][Full Text] [Related]
32. Insulin sensitivity is increased and fat oxidation after a high-fat meal is reduced in normal-weight healthy men with strong familial predisposition to overweight.
Giacco R; Clemente G; Busiello L; Lasorella G; Rivieccio AM; Rivellese AA; Riccardi G
Int J Obes Relat Metab Disord; 2003 Jul; 27(7):790-6. PubMed ID: 12821963
[TBL] [Abstract][Full Text] [Related]
33. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
[TBL] [Abstract][Full Text] [Related]
34. Is there heterozygote expression of growth hormone receptor deficiency?
Rosenbloom AL; Guevara-Aguirre J; Rosenfeld RG; Fielder PJ
Acta Paediatr Suppl; 1994 Apr; 399():125-7. PubMed ID: 7949596
[TBL] [Abstract][Full Text] [Related]
35. Atypical defects resulting in growth hormone insensitivity.
Wit JM; de Luca F
Growth Horm IGF Res; 2016 Jun; 28():57-61. PubMed ID: 26670721
[TBL] [Abstract][Full Text] [Related]
36. Circulating IGF binding protein-1 is inversely associated with leptin in non-obese men and obese postmenopausal women.
Söderberg S; Ahrén B; Eliasson M; Dinesen B; Brismar K; Olsson T
Eur J Endocrinol; 2001 Mar; 144(3):283-90. PubMed ID: 11248749
[TBL] [Abstract][Full Text] [Related]
37. Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography.
Evans DJ; Murray R; Kissebah AH
J Clin Invest; 1984 Oct; 74(4):1515-25. PubMed ID: 6148358
[TBL] [Abstract][Full Text] [Related]
38. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
[TBL] [Abstract][Full Text] [Related]
39. Fanconi Anemia and Laron Syndrome.
Castilla-Cortazar I; de Ita JR; Aguirre GA; Castorena-Torres F; Ortiz-Urbina J; García-Magariño M; de la Garza RG; Diaz Olachea C; Elizondo Leal MI
Am J Med Sci; 2017 May; 353(5):425-432. PubMed ID: 28502327
[TBL] [Abstract][Full Text] [Related]
40. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Guevara-Aguirre J; Diamond FB; Baxter RC; Rosenbloom AL; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Dec; 77(6):1683-9. PubMed ID: 7505289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
